These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 28427529)

  • 21. Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse.
    Fossard G; Ferlay C; Nicolas-Virelizier E; Rey P; Ducray F; Jouanneau E; Faurie P; Belhabri A; Sunyack MP; Chassagne-Clément C; Thiesse P; Sebban C; Biron P; Blay JY; Ghesquières H
    Eur J Cancer; 2017 Feb; 72():12-19. PubMed ID: 28012348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Primary CNS Lymphoma: Maximizing Clinical Benefit, Minimizing Neurotoxicity.
    Song KW; Batchelor T
    Curr Oncol Rep; 2021 Sep; 23(11):132. PubMed ID: 34524547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary central nervous system lymphoma.
    de Koning ME; Hof JJ; Jansen C; Doorduijn JK; Bromberg JEC; van der Meulen M
    J Neurol; 2024 May; 271(5):2906-2913. PubMed ID: 38112784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary CNS lymphoma in immunocompetent patients.
    Sierra del Rio M; Rousseau A; Soussain C; Ricard D; Hoang-Xuan K
    Oncologist; 2009 May; 14(5):526-39. PubMed ID: 19433528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study.
    Doorduijn JK; van Imhoff GW; van der Holt B; Schouten HC; Schaafsma MR; MacKenzie MA; Baars JW; Kersten MJ; Lugtenburg PJ; van den Bent MJ; Enting RH; Spoelstra FM; Poortmans P; Bromberg JEC
    Hematol Oncol; 2017 Dec; 35(4):497-503. PubMed ID: 27530779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose Thiotepa, Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplantation as Upfront Consolidation for Systemic Non-Hodgkin Lymphoma With Synchronous Central Nervous System Involvement.
    Qualls D; Sullivan A; Li S; Brunner AM; Collier K; Hochberg E; Armand P; Batchelor TT; Chen YB; DeFilipp Z
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):884-888. PubMed ID: 28870642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary central nervous system lymphoma: overview of current treatment strategies.
    Brastianos PK; Batchelor TT
    Hematol Oncol Clin North Am; 2012 Aug; 26(4):897-916. PubMed ID: 22794289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma.
    Bierman P; Giglio P
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):597-609, v. PubMed ID: 16083825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.
    Abrey LE; Moskowitz CH; Mason WP; Crump M; Stewart D; Forsyth P; Paleologos N; Correa DD; Anderson ND; Caron D; Zelenetz A; Nimer SD; DeAngelis LM
    J Clin Oncol; 2003 Nov; 21(22):4151-6. PubMed ID: 14615443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary CNS lymphoma.
    Batchelor T; Loeffler JS
    J Clin Oncol; 2006 Mar; 24(8):1281-8. PubMed ID: 16525183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary Central Nervous System Lymphoma.
    Sinicrope K; Batchelor T
    Neurol Clin; 2018 Aug; 36(3):517-532. PubMed ID: 30072069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The possible role of maintenance treatment for primary central nervous system lymphoma.
    Bairey O; Siegal T
    Blood Rev; 2018 Sep; 32(5):378-386. PubMed ID: 29551465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary Central Nervous System Lymphoma.
    Löw S; Batchelor TT
    Semin Neurol; 2018 Feb; 38(1):86-94. PubMed ID: 29548055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and treatment of primary CNS lymphoma.
    Korfel A; Schlegel U
    Nat Rev Neurol; 2013 Jun; 9(6):317-27. PubMed ID: 23670107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges in the management of primary central nervous system lymphoma.
    Sun X; Lv L; Wu Y; Cui Q; Sun S; Ji N; Liu Y
    Crit Rev Oncol Hematol; 2023 Aug; 188():104042. PubMed ID: 37277008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy.
    Ekenel M; Iwamoto FM; Ben-Porat LS; Panageas KS; Yahalom J; DeAngelis LM; Abrey LE
    Cancer; 2008 Sep; 113(5):1025-31. PubMed ID: 18618509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematopoietic stem cell transplantation in primary central nervous system lymphoma: a review of the literature.
    Gaut D; Schiller GJ
    Int J Hematol; 2019 Mar; 109(3):260-277. PubMed ID: 30671909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.
    Illerhaus G; Marks R; Ihorst G; Guttenberger R; Ostertag C; Derigs G; Frickhofen N; Feuerhake F; Volk B; Finke J
    J Clin Oncol; 2006 Aug; 24(24):3865-70. PubMed ID: 16864853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolving Treatments for Primary Central Nervous System Lymphoma.
    Ferreri AJM; Holdhoff M; Nayak L; Rubenstein JL
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():454-466. PubMed ID: 31099614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in Primary Central Nervous System Lymphoma.
    Patrick LB; Mohile NA
    Curr Oncol Rep; 2015 Dec; 17(12):60. PubMed ID: 26475775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.